Literature DB >> 29413521

Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.

Caline S Karam1, Jonathan A Javitch2.   

Abstract

Amphetamines (AMPHs) are potent psychostimulants that are widely used and abused, with profound medical and societal impact. Their actions at dopaminergic neurons are thought to mediate their therapeutic efficacy as well as their liability for abuse and dependence. AMPHs target the dopamine transporter (DAT), the plasmalemmal membrane protein that mediates the inactivation of released dopamine (DA) through its reuptake. AMPHs act as substrates for DAT and are known to cause mobilization of dopamine (DA) to the cell exterior via DAT-mediated reverse transport (efflux). It has become increasingly evident that the mechanisms that regulate AMPH-induced DA efflux are distinct from those that regulate DA uptake. Central to these mechanisms is the phosphorylation of the DAT amino (N)-terminus, which has been repeatedly demonstrated to facilitate DAT-mediated DA efflux, without impacting other aspects of DAT physiology. This review aims to summarize the current status of knowledge regarding DAT N-terminal phosphorylation and its regulation by protein modulators and the membrane microenvironment. A better understanding of these mechanisms may lead to the identification of novel therapeutic approaches that interfere selectively with the pharmacological effects of AMPHs without altering the physiological function of DAT.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine efflux; Kinases; Lipid rafts; Phosphatases; Psychostimulants; Vesicular monoamine transporters

Mesh:

Substances:

Year:  2017        PMID: 29413521      PMCID: PMC6341980          DOI: 10.1016/bs.apha.2017.09.002

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  147 in total

1.  Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.

Authors:  R A Vaughan; R A Huff; G R Uhl; M J Kuhar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

2.  Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Authors:  Jacob U Fog; Habibeh Khoshbouei; Marion Holy; William A Owens; Christian Bjerggaard Vaegter; Namita Sen; Yelyzaveta Nikandrova; Erica Bowton; Douglas G McMahon; Roger J Colbran; Lynette C Daws; Harald H Sitte; Jonathan A Javitch; Aurelio Galli; Ulrik Gether
Journal:  Neuron       Date:  2006-08-17       Impact factor: 17.173

Review 3.  How addictive drugs disrupt presynaptic dopamine neurotransmission.

Authors:  David Sulzer
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

Review 4.  Regulation of monoamine transporters: Role of transporter phosphorylation.

Authors:  Sammanda Ramamoorthy; Toni S Shippenberg; Lankupalle D Jayanthi
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

5.  Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization.

Authors:  Lankupalle D Jayanthi; Devadoss J Samuvel; Sammanda Ramamoorthy
Journal:  J Biol Chem       Date:  2004-02-19       Impact factor: 5.157

Review 6.  Protective and toxic roles of dopamine in Parkinson's disease.

Authors:  Juan Segura-Aguilar; Irmgard Paris; Patricia Muñoz; Emanuele Ferrari; Luigi Zecca; Fabio A Zucca
Journal:  J Neurochem       Date:  2014-03-18       Impact factor: 5.372

Review 7.  Regulation of ion transport proteins by membrane phosphoinositides.

Authors:  Nikita Gamper; Mark S Shapiro
Journal:  Nat Rev Neurosci       Date:  2007-12       Impact factor: 34.870

8.  Functional asymmetry of the amine transporter from chromaffin granules.

Authors:  R Maron; Y Stern; B I Kanner; S Schuldiner
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

9.  Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse.

Authors:  Christine T Sweeney; Mark A Sembower; Michelle D Ertischek; Saul Shiffman; Sidney H Schnoll
Journal:  J Addict Dis       Date:  2013

10.  PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.

Authors:  Peter J Hamilton; Andrea N Belovich; George Khelashvili; Christine Saunders; Kevin Erreger; Jonathan A Javitch; Harald H Sitte; Harel Weinstein; Heinrich J G Matthies; Aurelio Galli
Journal:  Nat Chem Biol       Date:  2014-06-01       Impact factor: 15.040

View more
  4 in total

1.  Quantifying secondary transport at single-molecule resolution.

Authors:  Gabriel A Fitzgerald; Daniel S Terry; Audrey L Warren; Matthias Quick; Jonathan A Javitch; Scott C Blanchard
Journal:  Nature       Date:  2019-11-13       Impact factor: 49.962

2.  The Role of the Dopamine Transporter in the Effects of Amphetamine on Sleep and Sleep Architecture in Drosophila.

Authors:  Caline S Karam; Brenna L Williams; Sandra K Jones; Jonathan A Javitch
Journal:  Neurochem Res       Date:  2021-02-25       Impact factor: 3.996

Review 3.  Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression.

Authors:  Renae M Ryan; Susan L Ingram; Annalisa Scimemi
Journal:  Front Cell Neurosci       Date:  2021-04-13       Impact factor: 5.505

4.  Functional Genomic Analysis of Amphetamine Sensitivity in Drosophila.

Authors:  Caline S Karam; Brenna L Williams; Irina Morozova; Qiaoping Yuan; Rony Panarsky; Yuchao Zhang; Colin A Hodgkinson; David Goldman; Sergey Kalachikov; Jonathan A Javitch
Journal:  Front Psychiatry       Date:  2022-02-18       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.